Macular degeneration trial will be first human test of Nobel-winning stem cell technique

18 January 2019
Source: STAT

Curing diabetes with stem cells? Everyone knew that would be hard. Parkinson’s disease? Harder. Alzheimer’s? Probably impossible. But age-related macular degeneration, a major cause of blindness? That was supposed to be low-hanging fruit. The cause of AMD is well-known, the recipe for turning stem cells into retinal cells works like a charm, and the eye is “immunoprivileged,” meaning immune cells

Read more Macular degeneration trial will be first human test of Nobel-winning stem cell technique

Blind Veterans UK, the Macular Society, Scottish War Blinded and Fight for Sight team up to fight for sight and tackle a leading cause of blindness

27 September 2018
Source: Action Against AMD

Fight for Sight is pleased to announce that it has entered into a new partnership to find a treatment for one of the world’s leading causes of blindness. Working with Blind Veterans UK, the Macular Society and Scottish War Blinded, the charities have launched a new collaboration to transform the funding of research to address age-related macular degeneration (AMD). The

Read more Blind Veterans UK, the Macular Society, Scottish War Blinded and Fight for Sight team up to fight for sight and tackle a leading cause of blindness

BBC News: NHS to save ‘hundreds of millions’ in landmark (Avsatin) drug ruling

21 September 2018
Source: BBC News

A landmark ruling against two leading drug companies could save the NHS “hundreds of millions” a year. Novartis and Bayer were trying to stop NHS doctors from prescribing a cheaper treatment for a serious eye condition. Twelve NHS bodies in the north east of England were offering patients Avastin, a cheaper alternative to the licensed drug, Lucentis. Health bosses said

Read more BBC News: NHS to save ‘hundreds of millions’ in landmark (Avsatin) drug ruling

Macular Society: Artificial intelligence company and four UK charities partner to find a cure for AMD

15 March 2018
Source: The Macular Society

BenevolentAI and Action Against AMD, a group of UK sight loss charities, have today announced their partnership to use BenevolentAI’s technology to find treatments and a potential cure for the leading cause of blindness in the UK – age-related macular degeneration (AMD). BenevolentAI is collaborating with a group of four charities partnering to find a cure for AMD. Blind Veterans UK, Fight

Read more Macular Society: Artificial intelligence company and four UK charities partner to find a cure for AMD

NICE guideline on age-related macular degeneration published

23 January 2018
Source: NICE

23/01/18 This final guideline has now been published on the NICE website. You can also find the supporting evidence, as well as all the stakeholder comments that they received during consultation and the responses to these comments. The comments were invaluable in helping them to develop and refine the guideline. They have also produced an equality impact assessment to support the

Read more NICE guideline on age-related macular degeneration published